DLD Asset Management’s Sarepta Therapeutics SRPT Stock Holding History

DLD Asset Management’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-9,500	Closed	-$1.23M	–	91
2024 Q1	$1.23M	Sell	9,500 -500	-5%	-$61.2K	0.17%	43
2023 Q4	$964K	Buy	+10,000	New	+$959K	0.12%	53
2021 Q3	–	Sell	-10,000	Closed	-$778K	–	150
2021 Q2	$778K	Sell	10,000 -10,000	-50%	-$758K	0.05%	97
2021 Q1	$1.49M	Buy	+20,000	New	+$1.85M	0.04%	103
2019 Q4	–	Sell	-31,500	Closed	-$2.37M	–	101
2019 Q3	$2.37M	Buy	+31,500	New	+$3.72M	0.12%	47
2019 Q1	–	Sell	-38,800	Closed	-$4.24M	–	106
2018 Q4	$4.24M	Buy	+38,800	New	+$4.85M	0.29%	47

Other funds holding SRPT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Avoro Capital Advisors

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Farallon Capital Management

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Bank of New York Mellon

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return